TerraBioGen Files Patent for Plant Growth Promoter

NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TerraBioGen Technologies Inc. (TSX VENTURE:TBG), a developer and marketer of
proprietary technologies for the production of organic-based, high-value
agricultural products from organic wastes, is pleased to announce today that it
has filed patent application for its F4 plant growth promoter.


The Company's scientists have determined that the F4 plant growth promoter is
one of the key active ingredients in its products that are responsible for
crop-yield increase. For several years, the Company has been conducting
intensive research toward the identification of the active ingredients in its
products.


Blair Heffelfinger, President and CEO of TerraBioGen, commented, "With our
expanded research department, we are very proud to have achieved this key
milestone in our development plans. This validates the performance increase in
our products that we have consistently achieved during field trials. We will
continue to isolate and identify additional active ingredients that impart the
unique benefits our products deliver in enhancing agricultural yields."


About TerraBioGen

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to
research and development to continue to improve the efficiency of its technology
and the quality of its agricultural products. It is further committed to
developing a worldwide marketing capability to ensure market acceptance of its
products.


This news release contains certain statements that may be deemed
"forward-looking" statements. Forward looking statements are statements that are
not historical facts and are generally, but not always, identified by the words
"expects", "plans", "anticipates", "believes", "intends", "estimates",
"projects", "potential" and similar expressions, or that events or conditions
"will", "would", "may", "could" or "should" occur. Although TerraBioGen believes
the expectations expressed in such forward-looking statements are based on
reasonable assumptions, such statements are not guarantees of future performance
and actual results may differ materially from those in forward-looking
statements. Forward-looking statements are based on the beliefs, estimates and
opinions of TerraBioGen's management on the date the statements are made. Except
as required by law, TerraBioGen undertakes no obligation to update these
forward-looking statements in the event that management's beliefs, estimates or
opinions, or other factors, should change.


THIS NEWS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION
TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT
CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE
NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED,
OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED
STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Terrabiogen Technologies (TSXV:TBG)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024